Rodrigo, Gustavo JPrice, David BAnzueto, AntonioSingh, DaveAltman, PabloBader, GiovanniPatalano, FrancescoFogel, RobertKostikas, Konstantinos2017-03-202017-03-202017-03-17Rodrigo, G J, Price, D B, Anzueto, A, Singh, D, Altman, P, Bader, G, Patalano, F, Fogel, R & Kostikas, K 2017, 'LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD : a systematic review and meta-analysis', International journal of chronic obstructive pulmonary disease , vol. 12, pp. 907—922. https://doi.org/10.2147/COPD.S1304821176-9106http://hdl.handle.net/2164/8355Acknowledgments The meta-analysis work was performed by Guruprasad Rao KS and Sharanbasappa Durg of Molecular Connections (P) Ltd, Bangalore, India, under the guidance of the manuscript authors and Novartis Pharma AG (Basel, Switzerland). Medical writing assistance was provided by Colette O’Sullivan, PhD, of Scriva Medical Communications Ltd, a professional medical writer funded by Novartis. Development of the manuscript was supported by Novartis Pharma AG (Basel, Switzerland). The authors received no compensation related to the development of the manuscript.161413955engLABA/LAMA combinationsCOPDLAMALABA/ICSmeta-analysisR MedicineRJournal article10.2147/COPD.S13048212